PubMed:32571880 / 1583-1846
Annnotations
LitCovid-OGER-BB
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T37 | 17-25 | CHEBI:36357 | denotes | molecule |
T38 | 17-25 | CHEBI:36357 | denotes | molecule |
T39 | 55-63 | SP_10 | denotes | SARS-CoV |
T40 | 136-146 | SP_7 | denotes | SARS-CoV-2 |
T41 | 180-190 | CHEBI:35222 | denotes | inhibitors |
T42 | 180-190 | CHEBI:35222 | denotes | inhibitors |
T43 | 213-222 | CHEBI:36357 | denotes | compounds |
T44 | 213-222 | CHEBI:36357 | denotes | compounds |
T45 | 245-253 | SP_7 | denotes | COVID-19 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T13 | 55-63 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T14 | 136-144 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T15 | 245-253 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T16 | 9-10 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T3 | 17-25 | Chemical | denotes | molecule | http://purl.obolibrary.org/obo/CHEBI_25367 |
T4 | 180-190 | Chemical | denotes | inhibitors | http://purl.obolibrary.org/obo/CHEBI_35222 |
T5 | 208-222 | Chemical | denotes | lead compounds | http://purl.obolibrary.org/obo/CHEBI_33585 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
29 | 55-63 | Species | denotes | SARS-CoV | Tax:694009 |
30 | 136-146 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
31 | 245-253 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T11 | 0-263 | Sentence | denotes | Finally, a small molecule previously shown to bind the SARS-CoV pseudoknot and inhibit -1 PRF was similarly effective against -1 PRF in SARS-CoV-2, suggesting that such frameshift inhibitors may be promising lead compounds to combat the current COVID-19 pandemic. |
sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T11 | 0-263 | Sentence | denotes | Finally, a small molecule previously shown to bind the SARS-CoV pseudoknot and inhibit -1 PRF was similarly effective against -1 PRF in SARS-CoV-2, suggesting that such frameshift inhibitors may be promising lead compounds to combat the current COVID-19 pandemic. |
mondo_disease
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T13 | 55-63 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T14 | 136-146 | Disease | denotes | SARS-CoV-2 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T15 | 245-253 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
NCBITAXON
Id | Subject | Object | Predicate | Lexical cue | db_id |
---|---|---|---|---|---|
T10 | 55-63 | OrganismTaxon | denotes | SARS-CoV | 694009 |
T11 | 136-144 | OrganismTaxon | denotes | SARS-CoV | 694009 |